Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments
- 1 April 2003
- Vol. 38 (2) , 157-160
- https://doi.org/10.1016/s0896-6273(03)00195-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal FunctionPublished by Elsevier ,2003
- LINKAGEANALYSIS INPSYCHIATRICDISORDERS: The Emerging PictureAnnual Review of Genomics and Human Genetics, 2002
- BDNF‐mediated signal transduction is modulated by GSK3β and mood stabilizing agentsJournal of Neurochemistry, 2002
- A common mechanism of action for three mood-stabilizing drugsNature, 2002
- Neurobiology of DepressionNeuron, 2002
- The Mood Stabilizer Valproic Acid Activates Mitogen-activated Protein Kinases and Promotes Neurite GrowthJournal of Biological Chemistry, 2001
- Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illnessBiological Psychiatry, 1999
- The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNSJournal of Neurochemistry, 1999
- A molecular mechanism for the effect of lithium on development.Proceedings of the National Academy of Sciences, 1996
- Neural and developmental actions of lithium: A unifying hypothesisCell, 1989